Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2/STAT3 and TGF-β/Smad3 pathways in vivo

References

• Nel AE, Parak WJ, Chan WC, et al. Where are we heading in nanotechnology environmental health and safety and materials characterization? ACS Nano. 2015;9(6):5627–5630. doi:10.1021/acsnano.5b0349626100220
   PubMed Web of Science ®Google Scholar
• Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH. The nanosilica hazard: another variable entity. Part Fibre Toxicol. 2010;7(1):39. doi:10.1186/1743-8977-7-3921126379
   PubMed Web of Science ®Google Scholar
• Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med. 2010;267(1):89–105. doi:10.1111/j.1365-2796.2009.02187.x20059646
   PubMed Web of Science ®Google Scholar
• Tang L, Cheng J. Nonporous silica nanoparticles for nanomedicine application. Nano Today. 2013;8(3):290–312. doi:10.1016/j.nantod.2013.04.00723997809
   PubMed Web of Science ®Google Scholar
• WHO. WHO Guidelines On Protecting Workers From Potential Risks Of Manufactured Nanomaterials. Geneva: World Health Organization; 2017.
   Google Scholar
• Xu R, Zhang G, Mai J, et al. An injectable nanoparticle generator enhances delivery of cancer therapeutics. Nat Biotechnol. 2016;34(4):414–418. doi:10.1038/nbt.350626974511
   PubMed Web of Science ®Google Scholar
• Benezra M, Penate-Medina O, Zanzonico PB, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest. 2011;121(7):2768–2780. doi:10.1172/JCI4560021670497
   PubMed Web of Science ®Google Scholar
• Murugadoss S, Lison D, Godderis L, et al. Toxicology of silica nanoparticles: an update. Arch Toxicol. 2017;91(9):2967–3010. doi:10.1007/s00204-017-1993-y28573455
   PubMed Web of Science ®Google Scholar
• Yu Y, Duan J, Li Y, et al. Silica nanoparticles induce liver fibrosis via TGF-beta1/Smad3 pathway in ICR mice. Int J Nanomedicine. 2017;12:6045–6057. doi:10.2147/IJN.S13230428860765
   PubMed Web of Science ®Google Scholar
• Yu Y, Li Y, Wang W, et al. Acute toxicity of amorphous silica nanoparticles in intravenously exposed ICR mice. PLoS One. 2013;8(4):e61346. doi:10.1371/journal.pone.006134623593469
   PubMed Web of Science ®Google Scholar
• Xie G, Sun J, Zhong G, Shi L, Zhang D. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch Toxicol. 2010;84(3):183–190. doi:10.1007/s00204-009-0488-x19936708
   PubMed Web of Science ®Google Scholar
• Zhuravskii S, Yukina G, Kulikova O, et al. Mast cell accumulation precedes tissue fibrosis induced by intravenously administered amorphous silica nanoparticles. Toxicol Mech Methods. 2016;26(4):260–269. doi:10.3109/15376516.2016.116934127055490
   PubMed Web of Science ®Google Scholar
• Mohammadpour R, Yazdimamaghani M, Cheney DL, Jedrzkiewicz J, Ghandehari H. Subchronic toxicity of silica nanoparticles as a function of size and porosity. J Control Release. 2019;304:216–232. doi:10.1016/j.jconrel.2019.04.04131047961
   PubMed Web of Science ®Google Scholar
• Iwaisako K, Hatano E, Taura K, et al. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells. J Hepatol. 2008;49(5):768–778. doi:10.1016/j.jhep.2008.05.02618804890
   PubMedGoogle Scholar
• Morris AS, Adamcakova-Dodd A, Lehman SE, et al. Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs. Toxicol Lett. 2016;241:207–215. doi:10.1016/j.toxlet.2015.11.00626562768
   PubMedGoogle Scholar
• Maser E, Schulz M, Sauer UG, et al. In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials. Mutat Res Genet Toxicol Environ Mutagen. 2015;794:57–74. doi:10.1016/j.mrgentox.2015.10.00526653985
   PubMed Web of Science ®Google Scholar
• Zhang J, Ren L, Zou Y, et al. Silica nanoparticles induce start inhibition of meiosis and cell cycle arrest via down-regulating meiotic relevant factors. Toxicol Res (Camb). 2016;5(5):1453–1464. doi:10.1039/c6tx00236f30090449
   PubMedGoogle Scholar
• Yang H, Wu QY, Li MY, Lao CS, Zhang YJ. Pulmonary toxicity in rats caused by exposure to intratracheal instillation of SiO2 nanoparticles. Biomed Environ Sci. 2017;30(4):264–279. doi:10.3967/bes2017.03628494836
   PubMed Web of Science ®Google Scholar
• Yang M, Jing L, Wang J, et al. Macrophages participate in local and systemic inflammation induced by amorphous silica nanoparticles through intratracheal instillation. Int J Nanomedicine. 2016;11:6217–6228. doi:10.2147/IJN.S11649227920528
   PubMed Web of Science ®Google Scholar
• Choi M, Cho W-S, Han BS, et al. Transient pulmonary fibrogenic effect induced by intratracheal instillation of ultrafine amorphous silica in A/J mice. Toxicol Lett. 2008;182(1–3):97–101. doi:10.1016/j.toxlet.2008.08.01918835341
   PubMedGoogle Scholar
• Ferri C, Artoni E, Sighinolfi GL, et al. High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: possible pathogenetic role in disease phenotypes. Semin Arthritis Rheum. 2018. doi:10.1016/j.semarthrit.2018.06.009
   PubMed Web of Science ®Google Scholar
• Wang F, Gao F, Lan M, Yuan H, Huang Y, Liu J. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol In Vitro. 2009;23(5):808–815. doi:10.1016/j.tiv.2009.04.00919401228
   PubMed Web of Science ®Google Scholar
• Sun L, Li Y, Liu X, et al. Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol In Vitro. 2011;25(8):1619–1629. doi:10.1016/j.tiv.2011.06.01221723938
   PubMed Web of Science ®Google Scholar
• Osmond-McLeod MJ, Poland CA, Murphy F, et al. Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres. Part Fibre Toxicol. 2011;8:15. doi:10.1186/1743-8977-8-1521569450
   PubMed Web of Science ®Google Scholar
• Duan J, Yu Y, Yu Y, et al. Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K/Akt/mTOR signaling pathway. Int J Nanomedicine. 2014;9:5131–5141. doi:10.2147/IJN.S7107425395850
   PubMed Web of Science ®Google Scholar
• Momtaz S, Niaz K, Maqbool F, Abdollahi M, Rastrelli L, Nabavi SM. STAT3 targeting by polyphenols: novel therapeutic strategy for melanoma. Biofactors. 2017;43(3):347–370. doi:10.1002/biof.134527896891
   PubMed Web of Science ®Google Scholar
• Kundu JK, Surh Y.J. Emerging avenues linking inflammation and cancer. Free Radic Biol Med. 2012;52(9):2013–2037. doi:10.1016/j.freeradbiomed.2012.02.03522391222
   PubMed Web of Science ®Google Scholar
• Kundu J, Kim D-H, Chae IG, et al. Silicon dioxide nanoparticles induce COX-2 expression through activation of STAT3 signaling pathway in HaCaT cells. Toxicol In Vitro. 2018;52:235–242. doi:10.1016/j.tiv.2018.06.00829894800
   PubMedGoogle Scholar
• Razdan N, Vasilopoulos T, Herbig U. Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts. Aging Cell. 2018;e12838. doi:10.1111/acel.1283830244523
   PubMedGoogle Scholar
• Kolb M. Inflammation and dysregulated fibroblast proliferation–new mechanisms? Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(Suppl 1):21–26.24081240
   PubMedGoogle Scholar
• Celada LJ, Kropski JA, Herazo-Maya JD, et al. PD-1 up-regulation on CD4(+) T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production. Sci Transl Med. 2018;10(460):eaar8356. doi:10.1126/scitranslmed.aao449630257954
   PubMedGoogle Scholar
• Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A. 2006;103(35):13180–13185. doi:10.1073/pnas.060566910316924102
   PubMed Web of Science ®Google Scholar
• Willis BC, duBois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc. 2006;3(4):377–382. doi:10.1513/pats.200601-004TK16738204
   PubMedGoogle Scholar
• Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007;127(3):526–537. doi:10.1038/sj.jid.570061317299435
   PubMed Web of Science ®Google Scholar